Cryo Cell International (CCEL) EPS (Weighted Average and Diluted) (2010 - 2026)

Cryo Cell International (CCEL) has 17 years of EPS (Weighted Average and Diluted) data on file, last reported at $0.01 in Q1 2026.

• EPS (Weighted Average and Diluted) for Q1 2026 came in at $0.01, down 66.67% year-over-year; the trailing twelve-month figure through Feb 2026 was -$0.33 (down 1750.0% YoY), and the FY2025 annual result was -$0.3, down 700.0% from the prior year.
• EPS (Weighted Average and Diluted) improved to $0.01 in Q1 2026 per CCEL's latest filing, from -$0.47 in the prior quarter.
• Over five years, EPS (Weighted Average and Diluted) peaked at $0.13 in Q3 2024 and troughed at -$1.34 in Q4 2023.
• A 5-year average of -$0.06 and a median of $0.07 in 2022 frame the typical range for EPS (Weighted Average and Diluted).
• The sharpest annual moves came in 2022 and 2023: EPS (Weighted Average and Diluted) soared 225.0% in 2022, then slumped 1440.0% in 2023.
• A 5-year view of EPS (Weighted Average and Diluted) shows it stood at $0.1 in 2022, then tumbled by 1440.0% to -$1.34 in 2023, then jumped by 83.58% to -$0.22 in 2024, then plunged by 113.64% to -$0.47 in 2025, then jumped by 102.13% to $0.01 in 2026.
• Business Quant data shows CCEL's EPS (Weighted Average and Diluted) at $0.01 in Q1 2026, -$0.47 in Q4 2025, and $0.09 in Q3 2025.